Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 5, 2013, Pages 919-924

  Poullis, Michael ^a   Mcshane, James ^a   Shaw, Mathew ^a   Shackcloth, Michael ^a   Page, Richard ^a   Mediratta, Neeraj ^a   Gosney, John ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Lung cancer; Outcome; Smoking; Surgical treatment

Indexed keywords

ALCOHOL; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INSULIN TREATMENT; LUNG ADENOCARCINOMA; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SURVIVAL TIME;

AGED; ANALYSIS OF VARIANCE; FEMALE; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84876822694     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs464     Document Type: Article

References (22)

1. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, Yasukawa T et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999;17:2086-91.
2. Sawabata N, Miyoshi S, Matsumura A, Ohta M, Maeda H, Sueki H et al. Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma. Gen Thorac Cardiovasc Surg 2007;55: 420-4.
3. Poullis M. Myocardial stunning and dopamine receptor polymorphism. Eur J Cardiothorac Surg 1999;15:553-4.
4. Robinson BM, Kennedy C, Mclean J, Mccaughan BC. Node-negative non-small-cell lung cancer: pathological staging and survival in 1765 consecutive cases. J Thorac Oncol 2011;6:1691-6.
5. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64: 8919-23.
6. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I et al. EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-11.
7. Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002;156:813-23.
8. Fontaine E, Mcshane J, Carr M, Shackcloth M, Mediratta N, Page R et al. Should we operate on microscopic N2 non-small cell lung cancer? Interact CardioVasc Thorac Surg 2011;12:956-61.
9. Meguid RA, Hooker CM, Harris J, Xu L, Westra WH, Sherwood JT et al. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers. Chest 2010;138:500-9.
10. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801.
11. Santoro IL, Ramos RP, Franceschini J, Jamnik S, Fernandes AL. Non-small cell lung cancer in never smokers: a clinical entity to be identified. Clinics (Sao Paulo) 2011;66:1873-7.
12. Joshi V, Mcshane J, Page R, Carr M, Mediratta N, Shackcloth M et al. Clinical upstaging of non-small cell lung cancer that extends across the fissure: implications for non-small cell lung cancer staging. Ann Thorac Surg 2011;91:350-3.
13. Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczesna A, Juhasz E et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol 2010;11:521-9.
14. Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 2012;13:239-46.
15. Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 2011;12:735-42.
16. Cooke DT, Nguyen DV, Yang Y, Chen SL, Yu C, Calhoun RF. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg 2010;90:943-8.
17. Kawai H, Tada A, Kawahara M, Nakai K, Maeda H, Saitou R et al. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer-a multicenter study. Lung Cancer 2005;49: 63-70.
18. Janjigian YY, Mcdonnell K, Kris MG, Shen R, Sima CS, Bach PB et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer 2010;116:670-5.
19. Poullis M, Mcshane J, Shaw M, Page R, Shackcloth M, Mediratta N. Framingham risk-based survival of non-small-cell lung cancer. Asian Cardiovasc Thorac Ann 2012;20:30-5.
20. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350: 351-60.
21. Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am 2011;20:605-18.
22. Fontaine E, Mcshane J, Carr M, Shackcloth M, Mediratta N, Page R et al. Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-smallcell lung cancer? Eur J Cardiothorac Surg 2011;40:642-6.